Xiao-Peng Zhang

Xiao-Peng Zhang

Auto-generated profile, based on publicly available information

Xiao-Peng Zhang

Department of Gastroenterology , Union Hospital , Tongji Medical College , Huazhong University of Science and Technology , Wuhan , China , tjmu.edu.cn

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Journal of Immunology Research
Verified
Journal Article
Open access
PDF file
XZXiao-Peng Zhang
Xiao-Peng Zhang
YCYidong Chen
Yidong Chen
QYQi Yu
Qi Yu
FLFang Liu
Fang Liu
JLJia-Min Li
Jia-Min Li
LZLiangru Zhu
Liangru Zhu
Autoimmune diseases (AIDs) are characterized by a breakdown in immune tolerance, wherein the patient’s immune system fails to recognize self‐tissues and subsequently attacks the body’s organs and tissues. Although there are many therapeutic medicines targeting the pathogenic mechanisms, there is currently a lack of curative or long‐term symptom control options. Chimeric antigen receptor (CAR) cells are engineered cells that express multifunctional synthetic receptors. These CAR cells specifically target killer pathogenic immune cells and offer a novel approach to treating AIDs by modulating the immune microenvironment. Recent studies have demonstrated satisfactory outcomes with this method in managing autoimmune conditions. In our review paper, we provide a comprehensive summary of previous cases utilizing CAR cell therapy for AIDs. We hope that our review will provide clinicians with more options for the treatment of AIDs.